Evidence map›Paper›PMID 27183602›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Dual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell-Mediated Viral Clearance.

Daniela Michlmayr, Susana V Bardina, Carlos A Rodriguez, Alexander G Pletnev, Jean K Lim

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chemokine receptor CCR5 correlates with functional CD8FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniela MichlmayrDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and.
Susana V BardinaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and.
Carlos A RodriguezDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and.
Alexander G PletnevLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Jean K LimDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; and jean.lim@mssm.edu.
Icahn School of Medicine at Mount Sinai · USNational Institutes of Health · US

Funding

Development Of New Approaches To Vaccines Against TBEV and West Nile VirusZIAAI000637 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PLETNEV, ALEXANDER · 2009 to 2022
$19.1M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Vaccines Against Tick Borne Encephalitis VirusZ01AI000637 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PLETNEV, ALEXANDER · 1992 to 2008
$3.8M
Chemokine regulation of myeloid cell populations during West Nile virus infectionR01AI108715 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2014 to 2017
$1.4M
Chemokine regulation of inflammatory monocytes during West Nile virus infectionF31AI110071 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BARDINA, SUSANA · 2014 to 2016
$109k
Intramural NIH HHS Z01 AI000637NIAID NIH HHS F31 AI110071NIAID NIH HHS R01 AI108715NIAID NIH HHS T32 AI007647
6 · The paper itself

Abstract

Tick-borne encephalitis virus (TBEV) is a vector-transmitted flavivirus that causes potentially fatal neurologic infection. There are thousands of cases reported annually, and despite the availability of an effective vaccine, the incidence of TBEV is increasing worldwide. Importantly, up to 30% of affected individuals develop long-term neurologic sequelae. We investigated the role of chemokine receptor Ccr5 in a mouse model of TBEV infection using the naturally attenuated tick-borne flavivirus Langat virus (LGTV). Ccr5-deficient mice presented with an increase in viral replication within the CNS and decreased survival during LGTV encephalitis compared with wild-type controls. This enhanced susceptibility was due to the temporal lag in lymphocyte migration into the CNS. Adoptive transfer of wild-type T cells, but not Ccr5-deficient T cells, significantly improved survival outcome in LGTV-infected Ccr5-deficient mice. Concomitantly, a significant increase in neutrophil migration into the CNS in LGTV-infected Ccr5(-/-) mice was documented at the late stage of infection. Ab-mediated depletion of neutrophils in Ccr5(-/-) mice resulted in a significant improvement in mortality, a decrease in viral load, and a decrease in overall tissue damage in the CNS compared with isotype control-treated mice. Ccr5 is crucial in directing T cells toward the LGTV-infected brain, as well as in suppressing neutrophil-mediated inflammation within the CNS.

Indexed as

AnimalsCentral Nervous System Viral DiseasesEncephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneInflammationMiceMice, Inbred C57BLMice, KnockoutNeutrophilsReceptors, CCR5T-LymphocytesVirus ReplicationCCR5 protein, mouseReceptors, CCR5

Identifiers

PMID27183602
PMCPMC4973474
OpenAlexW2344238816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.